Alkermes
ALKS
#3093
Rank
$4.87 B
Marketcap
$29.52
Share price
0.75%
Change (1 day)
-6.17%
Change (1 year)

Alkermes (ALKS) - Net assets

Net assets on the balance sheet as of September 2025 : $1.73 Billion USD

According to Alkermes's latest financial reports the company has $1.73 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alkermes - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$1.46 B21.81%
2023-12-31$$1.20 B15.23%
2022-12-31$$1.04 B-6.19%
2021-12-31$$1.11 B4.27%
2020-12-31$$1.06 B-1.7%
2019-12-31$$1.08 B-7.33%
2018-12-31$$1.17 B-2.62%
2017-12-31$$1.20 B-0.55%
2016-12-31$$1.20 B-7.97%
2015-12-31$$1.31 B-5.91%
2014-12-31$$1.39 B
2013-03-31$$0.95 B11.54%
2012-03-31$$0.85 B117.81%
2011-03-31$$0.39 B-4.99%
2010-03-31$$0.41 B-5.12%
2009-03-31$$0.43 B42.44%
2008-03-31$$0.30 B50.06%
2007-03-31$$0.20 B512.54%
2006-03-31$$33.21 M707.78%
2005-03-31$$4.11 M-94.58%
2004-03-31$$75.92 M-1604.76%
2003-03-31$-$5.05 Million-105.06%
2002-03-31$$99.66 M-32.85%
2001-03-31$$0.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Acorda Therapeutics
ACOR
-$0.19 Billion-110.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B 973.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$79.27 B 4,473.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 5,270.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$45.97 B 2,552.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$7.25 B 318.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
$86.29 B 4,878.41%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
$44.75 B 2,481.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland